Ben Trotman’s tumor is completely gone after participating in a clinical trial to treat glioblastoma, one of the deadliest ...

Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.

Man with deadly glioblastoma shows no signs of disease after taking experimental immunotherapy drug ipilimumab, inspiring a ...

A new immunotherapy trial for the deadliest form of brain cancer, glioblastoma, is now recruiting patients after one ...

Ben Trotman, diagnosed with terminal glioblastoma in 2022, experienced a complete remission after receiving ipilimumab before ...

In a devastating turn of event, 40-year-old Ben Trotman was being diagnosed with the deadlist form of brain cancer in 2022, ...

A UCL-sponsored clinical trial for patients newly diagnosed with glioblastoma, an aggressive form of brain cancer, has opened ...

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Teddi Mellencamp is taking a “break from immunotherapy” due to side effects and in order to get her “body back feeling ...

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

In a major setback to Zydus Lifesciences, the Delhi High Court has restrained the company from launching its proposed ...